212 related articles for article (PubMed ID: 32866512)
41. Examining HSD3B1 as a possible biomarker to detect prostate cancer patients who are likely to progress on ADT.
Handy WF; Schmidt KT; Price DK; Figg WD
Cancer Biol Ther; 2020 Sep; 21(9):782-784. PubMed ID: 32791030
[TBL] [Abstract][Full Text] [Related]
42. Molecular biology of the 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase gene family.
Simard J; Ricketts ML; Gingras S; Soucy P; Feltus FA; Melner MH
Endocr Rev; 2005 Jun; 26(4):525-82. PubMed ID: 15632317
[TBL] [Abstract][Full Text] [Related]
43. Inheritance of a common androgen synthesis variant allele is associated with female COVID susceptibility in UK Biobank.
McManus JM; Sabharwal N; Bazeley P; Sharifi N
Eur J Endocrinol; 2022 May; 187(1):1-14. PubMed ID: 35521709
[TBL] [Abstract][Full Text] [Related]
44. Induction of 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase type 1 gene transcription in human breast cancer cell lines and in normal mammary epithelial cells by interleukin-4 and interleukin-13.
Gingras S; Moriggl R; Groner B; Simard J
Mol Endocrinol; 1999 Jan; 13(1):66-81. PubMed ID: 9892013
[TBL] [Abstract][Full Text] [Related]
45. 3β-Hydroxysteroid dehydrogenase isoforms in human aldosterone-producing adenoma.
Konosu-Fukaya S; Nakamura Y; Satoh F; Felizola SJ; Maekawa T; Ono Y; Morimoto R; Ise K; Takeda K; Katsu K; Fujishima F; Kasajima A; Watanabe M; Arai Y; Gomez-Sanchez EP; Gomez-Sanchez CE; Doi M; Okamura H; Sasano H
Mol Cell Endocrinol; 2015 Jun; 408():205-12. PubMed ID: 25458695
[TBL] [Abstract][Full Text] [Related]
46. Germline polymorphisms associated with impaired survival outcomes and somatic tumor alterations in advanced prostate cancer.
Chen WS; Feng EL; Aggarwal R; Foye A; Beer TM; Alumkal JJ; Gleave M; Chi KN; Reiter RE; Rettig MB; Evans CP; Small EJ; Sharifi N; Zhao SG
Prostate Cancer Prostatic Dis; 2020 Jun; 23(2):316-323. PubMed ID: 31745256
[TBL] [Abstract][Full Text] [Related]
47. Role of Cryptochrome-1 and Cryptochrome-2 in Aldosterone-Producing Adenomas and Adrenocortical Cells.
Tetti M; Castellano I; Venziano F; Magnino C; Veglio F; Mulatero P; Monticone S
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29874863
[TBL] [Abstract][Full Text] [Related]
48. HSD3B1 gene polymorphism and female pattern hair loss in women with polycystic ovary syndrome.
Tu YA; Lin SJ; Chen PL; Chou CH; Huang CC; Ho HN; Chen MJ
J Formos Med Assoc; 2019 Aug; 118(8):1225-1231. PubMed ID: 31056381
[TBL] [Abstract][Full Text] [Related]
49. Effects of Methoxychlor and Its Metabolite Hydroxychlor on Human Placental 3β-Hydroxysteroid Dehydrogenase 1 and Aromatase in JEG-3 Cells.
Liu S; Mao B; Bai Y; Liu J; Li H; Li X; Lian Q; Ge RS
Pharmacology; 2016; 97(3-4):126-33. PubMed ID: 26735933
[TBL] [Abstract][Full Text] [Related]
50. Homozygous HSD3B1(1245C) inheritance and poor outcomes in metastatic castration-resistant prostate cancer with abiraterone or enzalutamide: what does it mean?
Sharifi N
Ann Oncol; 2020 Sep; 31(9):1103-1105. PubMed ID: 32592760
[No Abstract] [Full Text] [Related]
51. Approaches to assessing 3β-hydroxysteroid dehydrogenase-1.
Alyamani M; McManus J; Patel M; Sharifi N
Methods Enzymol; 2023; 689():89-119. PubMed ID: 37802584
[TBL] [Abstract][Full Text] [Related]
52. Prostate Cancer Foundation Hormone-Sensitive Prostate Cancer Biomarker Working Group Meeting Summary.
Hofmann MR; Hussain M; Dehm SM; Beltran H; Wyatt AW; Halabi S; Sweeney C; Scher HI; Ryan CJ; Feng FY; Attard G; Klein E; Miyahira AK; Soule HR; Sharifi N
Urology; 2021 Sep; 155():165-171. PubMed ID: 33373705
[TBL] [Abstract][Full Text] [Related]
53. Opposite effects of prolactin and corticosterone on the expression and activity of 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase in rat skin.
Couet J; Martel C; Labrie Y; Luo S; Simard J; Labrie F
J Invest Dermatol; 1994 Jul; 103(1):60-4. PubMed ID: 8027581
[TBL] [Abstract][Full Text] [Related]
54. Characterization of human 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase gene and its expression in mammalian cells.
Lachance Y; Luu-The V; Labrie C; Simard J; Dumont M; de Launoit Y; Guérin S; Leblanc G; Labrie F
J Biol Chem; 1992 Feb; 267(5):3551. PubMed ID: 1737804
[No Abstract] [Full Text] [Related]
55. Trilostane, a 3β-hydroxysteroid dehydrogenase inhibitor, suppresses growth of hepatocellular carcinoma and enhances anti-cancer effects of sorafenib.
Lin JC; Liu CL; Chang YC; Cheng SP; Huang WC; Lin CH; Wu CY; Chen MJ
Invest New Drugs; 2021 Dec; 39(6):1493-1506. PubMed ID: 34031786
[TBL] [Abstract][Full Text] [Related]
56. Ziram inhibits aromatase activity in human placenta and JEG-3 cell line.
Chen L; Chen X; Chen X; Hu Z; Li X; Su Y; Li X; Ge RS
Steroids; 2017 Dec; 128():114-119. PubMed ID: 28951168
[TBL] [Abstract][Full Text] [Related]
57. Genetic linkage mapping of HSD3B1 and HSD3B2 encoding human types I and II 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase close to D1S514 and the centromeric D1Z5 locus.
Morissette J; Rhéaume E; Leblanc JF; Luu-The V; Labrie F; Simard J
Cytogenet Cell Genet; 1995; 69(1-2):59-62. PubMed ID: 7835088
[TBL] [Abstract][Full Text] [Related]
58. Association of HSD17B3 and HSD3B1 polymorphisms with acne vulgaris in Southwestern Han Chinese.
Yang XY; Wu WJ; Yang C; Yang T; He JD; Yang Z; He L
Dermatology; 2013; 227(3):202-8. PubMed ID: 24157973
[TBL] [Abstract][Full Text] [Related]
59. Hormonal regulation of steroidogenic enzyme gene expression in Leydig cells.
Payne AH; Youngblood GL; Sha L; Burgos-Trinidad M; Hammond SH
J Steroid Biochem Mol Biol; 1992 Dec; 43(8):895-906. PubMed ID: 22217834
[TBL] [Abstract][Full Text] [Related]
60. Conversion of abiraterone to D4A drives anti-tumour activity in prostate cancer.
Li Z; Bishop AC; Alyamani M; Garcia JA; Dreicer R; Bunch D; Liu J; Upadhyay SK; Auchus RJ; Sharifi N
Nature; 2015 Jul; 523(7560):347-51. PubMed ID: 26030522
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
